Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

MRNA-based gene expression for personalizing patient cancer therapy with an MDM2 antagonist

US Patent 9657351 · Granted May 23, 2017

Assignee

Inventors

View full patent text on Google Patents →